Liminatus Pharma, Inc. Class A Common Stock (LIMN) Live Share Price, Invest From India

Liminatus Pharma, Inc. Class A Common Stock Stock Performance

as on May 13, 2026 at 6:57 am IST

Day's Low
$0.19
Day's Price Range
$0.20
$0.20
5.00%
Downside
52 Week's Low
52 Week's High
$0.16
52-Week Price Range
$33.66
$0.20
20.40%
Downside
16730.00%
Upside

Liminatus Pharma, Inc. Class A Common Stock share price movements today

Previous Close: $0.20
Open: $0.20
Volume: 1.8M
Day's Low - High: $0.19 - $0.20
52 Week Low - High: $0.16 - $33.66

Liminatus Pharma, Inc. Class A Common Stock Historical Returns

1 Month Return: + 9.33 %
3 Month Return: -57.74 %
1 Year Return: -97.12 %
3 Year Return: 0 %
5 Year Return: 0 %

Liminatus Pharma, Inc. Class A Common Stock Stock Fundamentals & Key Indicators

Check Liminatus Pharma, Inc. Class A Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.1M

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

0.00%

Liminatus Pharma, Inc. Class A Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Liminatus Pharma, Inc. Class A Common Stock with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Liminatus Pharma, Inc. Class A Common Stock	NA	$9.1M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$39.4B	113.59%	74.13	12.55%
BeiGene, Ltd.	NA	$32.2B	NA	70.46	8.94%
Vertex Pharmaceuticals Inc	BUY	$109.1B	104.61%	25.51	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.9B	40.55%	17.45	29.65%

Stock Returns calculator for Liminatus Pharma, Inc. Class A Common Stock Stock including INR - Dollar returns

The Liminatus Pharma, Inc. Class A Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Liminatus Pharma, Inc. Class A Common Stock investment value today

Current value as on today

₹3,160

Returns

-₹96,840

(-96.84%)

Returns from Liminatus Pharma, Inc. Class A Common Stock Stock

-₹97,195 (-97.19%)

Dollar Impact

₹355 (+0.35%)

Indian Investors' Interest in Liminatus Pharma, Inc. Class A Common Stock Stock

Search interest for Liminatus Pharma, Inc. Class A Common Stock Stock has increased by 126% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 13, 2026 to May 13, 2026

Change:126% versus previous 30 day period

Liminatus Pharma, Inc. Class A Common Stock Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Dec 2024	Mar 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	0	-
Operating Income	0	-1	0	0	0	0
EBITDA	0	-1	0	0	-1	-8
Interest Expense	0	0	0	0	0	0
Depreciation	-	-	-	-	0	0
Income Before Tax	0	-1	0	0	-1	-8
Income Tax Expense	0	-	0	-	-	-
Net Income	0	-1	0	0	-1	-8
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Liminatus Pharma, Inc. Class A Common Stock Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-
Gross Profit	-	-	-	-
Operating Income	-2	-2	-2	-2
EBITDA	-2	-1	-2	-9
Interest Expense	0	0	0	0
Depreciation	-	-	-	0
Income Before Tax	-2	-1	-2	-10
Income Tax Expense	0	0	0	-
Net Income	-2	-1	-2	-10
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

Liminatus Pharma, Inc. Class A Common Stock Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Mar 2025	Sep 2025	Dec 2025
Net Income	-858	0	0	-1	-8
Operating Cash Flow	-903	0	-	0	0
Investing Cash Flow	248	1	-	0	0
Financing Cash Flow	700	0	-	11	-
Change in Cash	45	-1	-	0	0

Liminatus Pharma, Inc. Class A Common Stock Annual Cash Flow

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-2	-4	-2	-10
Operating Cash Flow	0	-3	-3	-9
Investing Cash Flow	263	0	1	0
Financing Cash Flow	5	0	1	11
Change in Cash	5	-4	0	0

Insights on Liminatus Pharma, Inc. Class A Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, BeOne Medicines Ltd has given 38.3% return, outperforming this stock by 135.2%
NEGATIVE IMPACT
Price Dip
In the last 3 months, LIMN stock has moved down by -45.5%

About Liminatus Pharma, Inc. Class A Common Stock

Liminatus Pharma, Inc., a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States. It develops IBA101, a humanized anti CD47 monoclonal antibody, which is in Phase I clinical trial for the treatment of advanced solid cancers, including non-small cell lung cancer. The company was founded in 2018 and is based in Cerritos, California.

Organisation	Liminatus Pharma, Inc. Class A Common Stock
Headquarters	12611 Hiddencreek Way, Cerritos, CA, United States, 90703
Industry	Biotechnology
CEO	Mr. Chris Kim J.D., L.L.M.
E-voting on shares	Click here to vote

Key Management of Liminatus Pharma, Inc. Class A Common Stock

Name	Title
Mr. Chris Kim J.D., L.L.M.	CEO & Chairman
Mr. Scott Dam	Chief Financial Officer
Dr. Beom Kyu Choi	Chief Technology Officer & Member of Scientific Advisory Board
Dr. Byong Chul Yoo Ph.D.	Chief Science Officer & Member of Scientific Advisory Board
Dr. Sang-jin Lee Ph.D.	Head of Research & Development and Member of Scientific Advisory Board

FAQs

What is Liminatus Pharma, Inc. Class A Common Stock share price today?

Liminatus Pharma, Inc. Class A Common Stock share price today is $0.2 as on May 13, 2026 at 1:27 am IST at the close of the market. Liminatus Pharma, Inc. Class A Common Stock share today touched a day high of $0.2 and a low of $0.19.

What is the 52 week high and 52 week low for Liminatus Pharma, Inc. Class A Common Stock share?

Liminatus Pharma, Inc. Class A Common Stock share touched a 52 week high of $33.66 on June 25, 2025 and a 52 week low of $0.16 on April 2, 2026. Liminatus Pharma, Inc. Class A Common Stock stock price today i.e. May 13, 2026 at 1:27 am IST is closed at $0.2,which is 99.41% down from its 52 week high and 25.63% up from its 52 week low.

What is Liminatus Pharma, Inc. Class A Common Stock's market capitalisation today?

Liminatus Pharma, Inc. Class A Common Stock market capitalisation is $0.00T as on May 13, 2026 at 1:27 am IST.

How to invest in Liminatus Pharma, Inc. Class A Common Stock Stock (LIMN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Liminatus Pharma, Inc. Class A Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Liminatus Pharma, Inc. Class A Common Stock Shares that will get you 7.5000 shares as per Liminatus Pharma, Inc. Class A Common Stock share price of $0.2 per share as on May 13, 2026 at 1:27 am IST.

What is the minimum amount required to buy Liminatus Pharma, Inc. Class A Common Stock Stock (LIMN) from India?

Indian investors can start investing in Liminatus Pharma, Inc. Class A Common Stock (LIMN) shares with as little as ₹95.618 or $1 (as of May 13, 2026 at 6:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.18 in Liminatus Pharma, Inc. Class A Common Stock stock (as per the Rupee-Dollar exchange rate as on May 13, 2026 at 6:41 am IST). Based on Liminatus Pharma, Inc. Class A Common Stock share’s latest price of $0.2 as on May 13, 2026 at 1:27 am IST, you will get 50.0000 shares of Liminatus Pharma, Inc. Class A Common Stock. Learn more about fractional shares .